Grifols Share Price Explained: Grifols Stock Trading
Date Modified: 20/10/2024
While not part of Europe’s top shares by market cap, Grifols (GRF.E) can offer trading opportunities for those seeking exposure to the European pharmaceutical market, particularly in plasma-derived products.
Let’s take a look at who Grifols is, the factors behind the stock’s movements, and how to trade Grifols shares:
TL;DR
- Grifols is a Barcelona-based global healthcare company specialising in plasma-derived medicines, transfusion medicine, and hospital solutions.
- Grifols shares are part of the Spanish index, the IBEX 35.
- Several factors can influence its share price, such as the earnings season, trader confidence, healthcare trends, the industry’s regulation, and competition, among others.
- Retail traders can use Contracts for Difference (CFDs) to trade short-term price movements of Grifols’ shares in both rising and falling markets.
What Is Grifols?
Grifols is a Spanish global healthcare leader specialising in plasma-derived therapies, hospital pharmacy products, and diagnostic solutions. The company develops, manufactures, and markets products to treat rare, chronic, and life-threatening diseases, serving hospitals, pharmacies, and healthcare professionals worldwide.
What Are the Potential Price Drivers of Grifols’ Shares?
Several price drivers can influence Grifols’ share price, including:
- Grifols’ financial performance.
- Healthcare market trends.
- Grifols’ partnerships and strategic acquisitions.
- Spending on Research & Development (R&D).
- Professional analysts’ ratings and opinions.
- Overall market sentiment on the Grifols stock.
- Regulation in the health and biopharma sector.
The History of Grifols’ Share Price
Since its Initial Public Offering (IPO) in 2006 on the Spanish Stock Exchange, Grifols’ stock price has followed a bullish trend until 2019, gaining 1,179.14% from 2.459 euros to 31.43 euros per share. Between 2019 and 2024, however, Grifols’ stock price has lost 273.70%, down to 8.48 euros (as of mid-August 2024).
Grifols Stock Trading: Opportunities and Risks
To get the most out of your trading, it's essential to weigh both the potential rewards and risks associated with the company's stock.
Potential Upsides of Trading Grifols
- Strong project execution and returns.
- Extensive distribution network.
- Large global plasma collection network.
- Expanding into growing healthcare markets.
- Advanced research and development.
- Technological advancements in manufacturing processes, potentially productivity.
- Increasing product demand, mostly due to the ageing population.
Potential Downsides of Trading Grifols
- New competitors can disrupt the market and reduce Grifols' market share.
- Operating in multiple countries exposes Grifols to varying political environments.
- The biotechnology industry is highly competitive, potentially impacting profitability.
- Powerful suppliers can negotiate prices, which can reduce profit margins.
- Demanding customers can pressure prices and profitability.
- Operating in different markets can have varying regulations impacting Grifols’ operations.
How to Trade Grifols’ Shares
There are several ways to trade in Grifols’ shares, each with its own advantages and risks. To choose the right financial product for you, you should consider your trading strategy, risk tolerance, time horizon, goals, trading knowledge and experience, availability, and trading capital.
Grifols Shares
To understand investing in Grifols shares, think of Grifols as a business venture. When you buy Grifols shares, you purchase a stake in that venture. As a shareholder, you have a claim on the company's assets and earnings.
If the business performs well, the value of your stake (share price) increases. Conversely, if the business encounters challenges, the value of your stake may decline.
ETFs that Include Grifols Stock
ETFs, or Exchange-Traded Funds, are financial products that track a specific index, stock sector, or commodity.
One way to trade Grifols without buying individual shares is through ETFs that include it in their diversified portfolios. You can then trade various types of ETFs such as healthcare ETFs, pharmaceutical ETFs, and Spain-focused ETFs, for instance.
CFDs on Grifols
If you don’t want to own physical shares of Grifols to speculate its share price over the short term, it is possible to trade CFDs or Contracts For Difference.
CFDs on Grifols act like speculations on whether the stock price will go up or down, depending on your analysis and stock trading strategy.
You don't actually own the stock, but you can open long and short positions. If you think the price will rise, you can speculate it will rise with long positions. If you think it will fall, you can speculate it will fall with shorting.
The risky part of CFD trading is leverage, allowing you to use a small amount of money to gain larger exposure in the underlying instrument. While it can potentially magnify your trading gains, it can also magnify trading losses as well.
Read our article “Why You Should Consider Trading CFDs” to get more insights into the reasons for trading CFDs.
Options on Grifols
Imagine you're speculating on whether Grifols' stock price will go up or down. Instead of buying the actual stock, you're buying a contract that gives you the right to buy or sell Grifols shares at a specific price on a specific date.
This contract is called an option.
A call option gives you the right to buy Grifols shares at a specific price if you expect the price to rise, while a put option grants you the right to sell Grifols shares at a specific price if you anticipate a price decline.
While you don't have to exercise the option, you should remember that options have expiration dates.
How to Start Trading Grifols’ Share CFDs with Plus500
Trading Grifols with Plus500 means that you intend to trade CFDs on Grifols, which means that you might first want to take the time to understand what CFD share trading is.
Once you have a solid foundation for your trading with a trading plan, you can open a demo trading account to test Plus500’s features and platform. This should also allow you to practise trading as a beginner. After learning how to trade with Plus500, you can open and monitor your CFD trading orders on Grifols.
If you’re ready to put your trading skills to the test, begin trading Grifols (GRF) CFDs on Plus500.
FAQs
Grifols is a global healthcare company specialising in biopharmaceuticals, diagnostics, bio supplies, and hospital solutions. The company is a leading provider of essential plasma-derived medicines and transfusion therapies.
Grifols' shares are traded on the Spanish stock exchanges of Barcelona, Madrid, Valencia, and Bilbao under the ticker GRF. Additionally, the company offers two American Depository Receipt (ADR) programs listed on the US over-the-counter market under the ticker GIKLY.
While trading hours for CFDs on Plus500 may vary, shares listed on the Spain 35 (IBX) index are typically traded from 9:00 AM to 5:30 PM local time.
Two primary methods traders use to forecast price movements are technical analysis and fundamental analysis. Technical analysis relies on historical price data, trading volume, and chart patterns to identify potential future price trends from the charts. Fundamental analysis focuses on a company's financial health, industry dynamics, and overall economic conditions to assess its intrinsic value and future prospects.
While long-term investing in Grifols focuses on position trading in a type of “buy and hold” trading strategy, trading Grifols shares usually refers to short-term trading styles such as intraday trading with day trading and trading focusing on price swings with swing trading. Knowing the difference between investing and trading will help you decide which trading style to trade Grifols is the best for you.
Learn More About Grifols
Related News & Market Insights
Get more from Plus500
Expand your knowledge
Learn insights through informative videos, webinars, articles, and guides with our comprehensive Trading Academy.
Explore our +Insights
Discover what’s trending in and outside of Plus500.
Stay up-to-date
Never miss a beat with the latest News & Markets Insights on major market events.